Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
U6 small nuclear RNA 8 (RNU6-8) is a member of the U6 family of small nuclear RNAs (snRNAs), which are essential non-coding RNA components of the spliceosome—the large macromolecular machine responsible for removing introns from precursor messenger RNA (pre-mRNA) during the process of pre-mRNA splicing in eukaryotic nuclei[1][3]. U6 snRNA (including all its paralogs/duplicated copies like RNU6-8) is highly conserved across species and plays a crucial catalytic role at the spliceosome core, mediating two critical transesterification steps in the splicing reaction by coordinating magnesium ions and forming essential base pairs with other snRNAs and pre-mRNA[1][3]. Copies such as RNU6-8 are among many U6 snRNA-related gene loci in the genome, reflecting U6’s evolutionary importance, though functional distinctions between individual U6 snRNA gene copies are often unclear[1]. U6 snRNA is not considered a protein-coding gene, nor is it a therapeutic target, receptor, enzyme, or transporter. Currently, there are no drugs that target U6 snRNAs, and these molecules themselves are not linked directly as biomarkers or therapeutic targets for disease, though defects in splicing can contribute indirectly to various pathologies[3][1]. The locus "RNU6-8" may also be a pseudogene or redundant locus among many highly similar U6-encoding genomic elements[1]. Notes on correctness/target status: - RNU6-8 is not a classical drug target (not a receptor, enzyme, etc.). - This entry is likely a generic, possibly redundant gene duplicate or pseudogene of U6 snRNA, and not associated with unique molecular targeting or biology different from canonical U6 snRNA[1]. - It is not a protein, nor is it typically considered under therapeutic target classes. Summary on ambiguity/mistakes: The name “RNU6-8” describes one of numerous nearly identical U6 snRNA gene loci, and as such does not correspond to a unique, active therapeutic target or receptor[1]. The main biological entity is U6 small nuclear RNA; “RNU6-8” is likely a designation for one of several such loci found in the genome, many of which may not be individually functional[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 8 (RNU6-8).